| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775774 | Urology | 2018 | 14 Pages |
Abstract
PE is estimated to affect up to 39% of men and is one of the most common self-reported male sexual disorders. There is an overlap among men with PE and those trying to achieve a pregnancy, and Promescent is a commonly used topical treatment for PE. Although there was no difference in SDF between the 2 groups, Promescent had a cytotoxic impact on sperm.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Melissa Sutton, Caitlin Hunn, Roxanne B. Summers-Colquitt, Shu-Hung Chen, Shahryar K. Kavoussi, Keikhosrow M. Kavoussi, Parviz K. Kavoussi,